DE69633780D1 - Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays - Google Patents

Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays

Info

Publication number
DE69633780D1
DE69633780D1 DE69633780T DE69633780T DE69633780D1 DE 69633780 D1 DE69633780 D1 DE 69633780D1 DE 69633780 T DE69633780 T DE 69633780T DE 69633780 T DE69633780 T DE 69633780T DE 69633780 D1 DE69633780 D1 DE 69633780D1
Authority
DE
Germany
Prior art keywords
troponin
disclosed
antibodies
complexes
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69633780T
Other languages
English (en)
Other versions
DE69633780T2 (de
DE69633780T3 (de
Inventor
F Buechler
H Mcpherson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere San Diego Inc
Original Assignee
Biosite Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27026061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69633780(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/423,582 external-priority patent/US5795725A/en
Application filed by Biosite Diagnostics Inc filed Critical Biosite Diagnostics Inc
Publication of DE69633780D1 publication Critical patent/DE69633780D1/de
Publication of DE69633780T2 publication Critical patent/DE69633780T2/de
Application granted granted Critical
Publication of DE69633780T3 publication Critical patent/DE69633780T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20Immunohistochemistry assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/971Capture of complex after antigen-antibody reaction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/973Simultaneous determination of more than one analyte
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/819Multifunctional antigen or antibody

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69633780T 1995-04-18 1996-04-18 Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays Expired - Lifetime DE69633780T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/423,582 US5795725A (en) 1995-04-18 1995-04-18 Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
US423582 1995-04-18
US08/633,248 US6174686B1 (en) 1995-04-18 1996-04-18 Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
PCT/US1996/005476 WO1996033415A1 (en) 1995-04-18 1996-04-18 Novel methods for the assay of troponin i and t and complexes of troponin i and t and selection of antibodies for use in immunoassays
US633248 1996-04-18

Publications (3)

Publication Number Publication Date
DE69633780D1 true DE69633780D1 (de) 2004-12-09
DE69633780T2 DE69633780T2 (de) 2005-11-03
DE69633780T3 DE69633780T3 (de) 2011-05-05

Family

ID=27026061

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633780T Expired - Lifetime DE69633780T3 (de) 1995-04-18 1996-04-18 Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays

Country Status (3)

Country Link
US (3) US6174686B1 (de)
AT (1) ATE281648T1 (de)
DE (1) DE69633780T3 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991907B1 (en) * 1995-04-18 2006-01-31 Biosite, Inc. Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
US6627404B1 (en) * 1995-04-18 2003-09-30 Biosite, Inc. Methods for improving the recovery of troponin I and T in membranes, filters and vessels
US7285418B2 (en) * 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
WO2002063302A1 (en) * 2001-02-07 2002-08-15 Immunomatrix Inc. A method for reducing heparin interference in diagnostic tests for cardiac troponin
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
GB0109925D0 (en) * 2001-04-23 2001-06-13 Axis Shield Asa Method
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US6461828B1 (en) 2001-09-04 2002-10-08 Syn X Pharma Conjunctive analysis of biological marker expression for diagnosing organ failure
WO2003046140A2 (en) * 2001-11-27 2003-06-05 Diagenics International Corporation Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
EP2386862A1 (de) * 2002-10-09 2011-11-16 DMI Biosciences, Inc. Verfahren und Kits zur Diagnose von Blinddarmentzündung
US7473548B2 (en) 2003-04-25 2009-01-06 Medtronic, Inc. Optical detector for enzyme activation
US20050096516A1 (en) * 2003-10-30 2005-05-05 Orhan Soykan Optical detector of organic analyte
US20050164409A1 (en) * 2003-12-10 2005-07-28 Kiernan Urban A. Method and apparatus for mass spectrometric immunoassay analysis of specific biological fluid proteins
US20050266503A1 (en) * 2004-05-24 2005-12-01 Esoterix, Inc. Simultaneous assay of target and target-drug binding
US8129352B2 (en) * 2004-09-16 2012-03-06 Avi Biopharma, Inc. Antisense antiviral compound and method for treating ssRNA viral infection
US20080318340A1 (en) * 2004-11-01 2008-12-25 Tokyo Metropolitan Organization For Medical Resear Method of Detecting Target Substances
US20060199280A1 (en) * 2005-03-03 2006-09-07 David Bar-Or Quantification of proteins
WO2007103568A2 (en) * 2006-03-09 2007-09-13 Biosite, Inc. Methods and compositions for the diagnosis of diseases of the aorta
WO2007106474A2 (en) * 2006-03-13 2007-09-20 Siemens Healthcare Diagnostics Inc. Reduction of platelet interference in plasma assay samples
US20080118924A1 (en) * 2006-05-26 2008-05-22 Buechler Kenneth F Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
US20080081354A1 (en) * 2006-10-02 2008-04-03 Cardiac Pacemakers, Inc. Devices, vectors and methods for inducible ischemia cardioprotection
JP5855332B2 (ja) 2006-10-18 2016-02-09 アクセラ インコーポレーテッド 広い濃度範囲にわたる複数アナライトの光回折による測定
JP5057402B2 (ja) * 2006-10-26 2012-10-24 アボット・ラボラトリーズ 内在性の抗分析物抗体を含有する試料中の分析物の免疫アッセイ
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
EP2095106B1 (de) * 2006-11-14 2013-03-20 Alere San Diego, Inc. Verfahren und zusammensetzungen zur diagnose und prognose von nierenarterienstenose
US7842472B2 (en) * 2006-11-14 2010-11-30 Alere International Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
EP2115477B1 (de) * 2007-01-25 2015-06-24 Roche Diagnostics GmbH Verwendung von igfbp-7 bei der beurteilung von herzversagen
JP5081930B2 (ja) * 2007-03-08 2012-11-28 エフ.ホフマン−ラ ロシュ アーゲー 心不全の評価におけるslim−1の使用
US8338189B2 (en) * 2008-03-05 2012-12-25 Axela Inc. Detection of biomarkers and biomarker complexes
CN102027374A (zh) * 2008-04-30 2011-04-20 霍夫曼-拉罗奇有限公司 Sfrp-3在评价心力衰竭中的用途
US9322825B2 (en) * 2008-08-27 2016-04-26 Lsi Medience Corporation Modified anti-heparin/PF4 complex antibody and HIT antibody standard
JP5528461B2 (ja) * 2008-10-17 2014-06-25 エフ.ホフマン−ラ ロシュ アーゲー 心不全の評価におけるビグリカンの使用
US8871730B2 (en) 2009-07-13 2014-10-28 Somagenics Inc. Chemical modification of short small hairpin RNAs for inhibition of gene expression
ES2512018T3 (es) 2009-07-27 2014-10-23 F. Hoffmann-La Roche Ag Utilización de mimecán en la evaluación de la insuficiencia cardiaca
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
KR101975993B1 (ko) 2011-02-25 2019-05-07 가부시키가이샤 엘에스아이 메디엔스 심근 트로포닌의 측정법
DE102012223378A1 (de) * 2012-12-17 2014-06-18 Charité - Universitätsmedizin Berlin In-vitro Verfahren und Kit zur Diagnose von akutem Koronarsyndrom
WO2014121252A1 (en) * 2013-02-04 2014-08-07 The General Hospital Corporation Biomarkers for stroke diagnosis
CA3103560C (en) 2014-09-26 2023-01-17 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
CN111735965B (zh) * 2020-07-02 2023-07-25 北京美联泰科生物技术有限公司 心肌肌钙蛋白i检测试剂和制备方法以及心肌肌钙蛋白i检测试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632901A (en) 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
CA2006408A1 (en) * 1988-12-27 1990-06-27 Susumu Iwasa Bispecific monoclonal antibody, its production and use
DE3922873A1 (de) 1989-04-25 1990-10-31 Boehringer Mannheim Gmbh Spezifische antikoerper gegen troponin t, ihre herstellung und verwendung in einem reagenz zur bestimmung von hermuskelnekrosen
WO1992005282A1 (en) * 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
CA2027434C (en) 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US5458852A (en) 1992-05-21 1995-10-17 Biosite Diagnostics, Inc. Diagnostic devices for the controlled movement of reagents without membranes
AU5685094A (en) 1992-12-09 1994-07-04 Allergan, Inc. Cleaning compositions and method for hydrophilic contact lenses
FR2701954B1 (fr) 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
ATE184400T1 (de) * 1993-05-17 1999-09-15 Fortron Bioscience Inc Assay für troponin i aus dem herzmuskel
US5574779A (en) 1995-05-01 1996-11-12 Bell Communications Research, Inc. Method and apparatus for provisioning network services

Also Published As

Publication number Publication date
US6579687B1 (en) 2003-06-17
ATE281648T1 (de) 2004-11-15
DE69633780T2 (de) 2005-11-03
US6939678B1 (en) 2005-09-06
DE69633780T3 (de) 2011-05-05
US6174686B1 (en) 2001-01-16

Similar Documents

Publication Publication Date Title
DE69633780D1 (de) Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays
EP0935140A3 (de) Verffahren zum Assay von Troponin I und T und Komplexen von Trpponon I und T und Auswahl von Antikörpern zur Verwendung in Immunoassays
Chu et al. Use of affinity capillary electrophoresis to measure binding constants of ligands to proteins
DE69733488D1 (de) Verfahren zur besserung der wiederfindung troponin i und t
ATE117435T1 (de) Spezifische antikörper gegen troponin t, ihre herstellung und verwendung in einem reagenz zur bestimmung von herzmuskelnekrosen.
DE69432709D1 (de) Nukleinsäure - Sandwichassay in Lösungsphase mit reduzierten Hintergrundsignalen
EP0165681A3 (de) Verfahren zum Nachweis von drogeninduzierter Thrombozytopenia und in diesem Verfahren zu verwendender Immunosatz
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
DE59008779D1 (de) Verfahren zur Bestimmung von HIV-Antikörpern.
ATE47231T1 (de) Verfahren zur bestimmung eines partners einer immunreaktion sowie reagens zur durchfuehrung dieses verfahrens.
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
YU46053B (sh) Postopek za specifično določanje vsebnosti serumskega fruktozamina
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
ATE148562T1 (de) Verfahren für den nachweis und/oder die bestimmung von hormonen
ATE79678T1 (de) Bestimmung von monokinen.
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
DE59108366D1 (de) Verfahren zur Bestimmung eines Analyten
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
AU5752186A (en) Method for measuring free ligands in biological fluids, and assay for measuring same
CA2213083A1 (en) Detection of antibody production
CN101206225A (zh) 化学发光免疫分析检测心肌钙蛋白t的方法
DE60109733D1 (de) Verfahren zur immobilisierung von affinen reagentien an hydrophoben festphasen
ATE127588T1 (de) Geminale diphenyl-derivate und ihre verwendung in immunotests.
Schramm et al. Continuous monitoring of analyte concentrations
CN1444033A (zh) 测定生物活性物质的目视荧光免疫分析法

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: BIOSITE INCORPORATED, SAN DIEGO, CALIF., US

8366 Restricted maintained after opposition proceedings
8310 Action for declaration of annulment